Chris Takimoto – Biography
Last update: April 13, 2026Executive profile
Chris was Director at Tizona Therapeutics, and Senior Vice President at Gilead Sciences. Chris Takimoto joined ALX Oncology in 2025.
Chris Takimoto is currentlyDirector at ALX Oncology - View - ALX Oncology org chart
Create your alert
to follow the career of Chris Takimoto.
Education
Chris Takimoto has a PhD in Pharmacology from Yale University in 1986 and a Residency Degree in Internal Medicine from University of California, Berkeley in 1989.
They have also studied at Yale University :
Find more alumni from Yale University
They have also studied at University of California, Berkeley :
Find more alumni from University of California, Berkeley
More about Chris Takimoto
Do you need to know more about Chris Takimoto? More results.
Participate
Social media
- Chris Takimoto on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Chris Takimoto
The colleagues of Chris Takimoto
Company Colleagues
- At ALX Oncology, Chris Takimoto has 19 colleagues including Jason Lettmann (CEO), Corey Goodman (Chairman of the Board)…
Industry Colleagues
- In the Biotechnology industry, Chris Takimoto has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Chris Takimoto.
Get in Touch
Here are a few tips for establishing great contacts.
